Lv1
40 积分 2024-10-03 加入
Design of Potent and Selective BCL6 Transcriptional Chemical Inducers of Proximity through Linker Optimization
3天前
已完结
Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases
5天前
已完结
Pharmacological Targeting of IRF4 As a Therapeutic Strategy for Multiple Myeloma
7天前
已完结
Discovery of Imidazo[1,2-a]pyrazine Derivatives as Potent ENPP1 Inhibitors
1个月前
已完结
Discovery of Orally Bioavailable Phthalazinone Analogues as an ENPP1 Inhibitor for STING-Mediated Cancer Immunotherapy
1个月前
已完结
Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5′-Pα,α-Dithiophosphate Analogues
1个月前
已完结
Inhibition of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1): A Medicinal Chemistry Approach at the Crossroad of Immunotherapy and Metabolic Modulation
1个月前
已完结
Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects
1个月前
已完结
Discovery and characterization of YSA64, a RBM39 degrader with in vivo efficacy and potent cellular activity in pediatric Ewing sarcoma A673
2个月前
已完结
Discovery of Naphthyridinone Derivatives as Selective PKMYT1/WEE1 Dual Inhibitors for Cancer Therapy
2个月前
已完结
皖公网安备34019202002308
